Application note: Detection of Mastitis Pathogens in Raw Milk
Detection of four pathogens of mastitis diseases using qTOWER³ in combination with extraction and detection systems for DNA diagnostics.
List view / Grid view
Detection of four pathogens of mastitis diseases using qTOWER³ in combination with extraction and detection systems for DNA diagnostics.
Combining automated nucleic acid extraction, photometry and qPCR for easy-to-use and highly sensitive species analysis of cheese.
SmartExtraction significantly simplifies the entire automated workflow of DNA extraction.
Challenge: One touch imaging of multiple proteins on the same blot with NIR fluorescent tags. Solution? Automated imaging with the UVP ChemStudio.
Proper signal visualization, detection, and quantification are paramount to the acquisition of accurate and reproducible data...
Challenge: Non-invasive imaging of a patient-derived orthotropic mouse model of pancreatic cancer expressing GFP. The solution? In vivo imaging.
In vivo imaging has been an indispensable and powerful tool in biomedical research, enabling a number of significant breakthrough discoveries.
22 October 2019 | By Halo Labs
Aqueous solubility of small molecule compounds is an essential parameter during the hit-to-lead stage of drug discovery as well as lead optimization and formulation. Low solubility can result in misleading ADMET/DMPK analyses if some fraction of a compound precipitates. Watch on-demand to find out more!
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
A study that identified 12 novel compounds that may prove valuable against new drug targets for leishmaniasis and Chagas disease was not without complication. Here, we discuss the findings but also the challenges the researchers reported in their hit-to-lead study.
Researchers have used a high-throughput screening method to test over 125,000 molecules and identify a new class of antibiotics.
A study using high-throughput screening has revealed some promising compounds that could be used in future cancer treatments.
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.
A compound that promotes the rebuilding of the protective sheath around nerve cells damaged in multiple sclerosis has been developed.